Correction for Morel et al., BMJ 331 (7528) 1299.

BMJ  2006;332:151 (21 January), doi:10.1136/bmj.332.7534.151

Correction

Achieving the millennium development goals for health: Cost effectiveness analysis of strategies to combat malaria in developing countries

A mix-up during submission led to the wrong version of table 3 being included in the full version of this paper (see bmj.com) by Chantal M Morel and colleagues (BMJ 2005;331:1299-302, 3 Dec). The R₀ value for case management with chloroquine should be 0.35 (rather than 0.3). The adherence for artemisinin based combination treatment should be 35% (not 40%), and neither that nor the adherence for non-artemisinin based treatment needs a footnote. Values for probability of success when patients were not fully compliant should be 35% for non-artemisinin based treatment and 0% for intermittent presumptive treatment during pregnancy (rather than 35% and 10% respectively, as given). These revised values also apply to table B on bmj.com.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Article

More on JAMA's policy on industry sponsored studies

Kenneth J Rothman and Stephen Evans
BMJ 2006 332: 489. [Extract] [Full Text]

Online poll

Find out more>>